DERMATA THERAPEUTICS INC's ticker is and the CUSIP is 249845116. A total of 5 filers reported holding DERMATA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101 | +180.6% | 5,610 | +211.7% | 0.00% | – |
| Q1 2023 | $36 | -73.9% | 1,800 | -73.9% | 0.00% | – |
| Q4 2022 | $138 | -86.2% | 6,905 | -24.1% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 9,100 | +178.5% | 0.00% | – |
| Q1 2022 | $1,000 | -66.7% | 3,267 | -53.1% | 0.00% | – |
| Q4 2021 | $3,000 | +50.0% | 6,960 | +132.0% | 0.00% | – |
| Q3 2021 | $2,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 175,000 | $19,000 | 0.10% |
| Warberg Asset Management LLC | 100,000 | $11,000 | 0.00% |
| ARMISTICE CAPITAL, LLC | 325,000 | $36,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 12,000 | $8,000 | 0.00% |